Ca
2+ is a central player in the excitation-contraction coupling of cardiac myocytes, the process that enables the heart to contract and relax. Mishandling of Ca
2+ is a central cause of both contractile dysfunction and arrhythmias in pathophysiological conditions such as heart failure (HF). Upon electrical excitation, Ca
2+ enters the myocytes via voltage-gated Ca
2+ channels and induces further Ca
2+ release from the sarcoplasmic reticulum (SR). This raises the free intracellular Ca
2+ concentration ([Ca
2+]
i), activating contraction. Relaxation is driven by [Ca
2+]
i decline, mainly due to re-uptake into the SR via SR Ca
2+-ATPase and extrusion via the sarcolemmal Na
+/Ca
2+ exchange, NCX. Intracellular Na
+ concentration ([Na
+]
i) is a main regulator of NCX, and thus [Na
+]
i plays an important role in controlling the cytosolic and SR [Ca
2+]. [Na
+]
i may have an even more important role in HF because NCX is generally upregulated. There are several pathways for Na
+ entry into the cells, whereas the Na
+/K
+ pump (NKA) is the main Na
+ extrusion pathway and therefore is essential in maintaining the transmembrane Na
+ gradient. Phospholemman is an important regulator of NKA function (decreasing [Na
+]
i affinity unless it is phosphorylated). Here we discuss the interplay between Ca
2+ and Na
+ in myocytes from normal and failing hearts.
View full abstract